Benitec GAAP EPS of -$0.26 misses by $0.03
Source: SeekingAlpha
2026-02-12 08:54:13 ET
More on Benitec
- Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
- Benitec GAAP EPS of -$0.22
- Seeking Alpha’s Quant Rating on Benitec
- Historical earnings data for Benitec
- Financial information for Benitec
Read the full article on Seeking Alpha
For further details see:
Benitec GAAP EPS of -$0.26 misses by $0.03
Benitec Biopharma Limited
NASDAQ: BNTC
BNTC Trading
-2.04% G/L:
$12.50 Last:
110,626 Volume:
$12.51 Open:
BNTC Latest News
March 09, 2026 07:00:00 am
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
BNTC Stock Data
$403,180,255
15,517,473
0.09%
20
N/A
Biotechnology & Life Sciences
Healthcare
US
Hayward
